Skip to content

Prism adaptation as a 2 week treatment

Prism adaptation as a 2 week treatment - PAir: Prism Adaptation in Rehabilitation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON39530
Enrollment
70
Registered
2012-08-06
Start date
2013-08-08
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CVA hemispatial neglect

Interventions

During prism adaption, patients wear prisms that shift their vision in one direction (e.g. 10° to the right). They will initially misreach in the direction of the prismatic shift (i.e. to the right)

Sponsors

Revalidatiecentrum De Hoogstraat
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: stroke, signs of neglect, 18-85 years of age, sufficient ability to comprehend and to communicate, as observed during speech therapy, neuropsychological assessment and/or neglect screening , sufficient motivation to participate in an intense rehabilitation treatment programme for two weeks

Exclusion criteria

Exclusion criteria: expected admission to the rehabilitation centre of less than 4 weeks

Design outcomes

Primary

MeasureTime frame
The effects of prism adaptation will be measured using several neuropsychological tests: star cancellation, line bisection, landmark task, drawing/copying, describing photographs, etc. Of all these tasks measures, such as reaction times, accuracy, number of perseverations, starting point/endpoint, procedure (e.g. systematic, random, etc) will be analysed. The second outcome measure will be differences in severity of neglect and daily impairments (as measured with the Catherine Bergego scale)

Secondary

MeasureTime frame
- balance board: laterale shift of centre of pressure in cm - force plate (posture): lateral shift of centre of pressure in cm - questionnaires: severity and frequency of neglect symptoms

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)